Abstract

Lamin A/C (LMNA) gene mutations are a known cause of familial dilated cardiomyopathy, but the precise mechanisms triggering disease progression remain unknown. We hypothesize that analysis of differentially expressed genes (DEGs) throughout the course of Lmna knockout (Lmna−/−)-induced cardiomyopathy may reveal novel Lmna-mediated alterations of signaling pathways leading to dilated cardiomyopathy. Although Lmna was the only DEG down-regulated at 1 week of age, we identified 730 and 1004 DEGs in Lmna−/− mice at 2 weeks and 1 month of age, respectively. At 2 weeks, Lmna−/− mice demonstrated both down- and up-regulation of the key genes involving cell cycle control, mitochondrial dysfunction, and oxidative phosphorylation, as well as down-regulated genes governing DNA damage repair and up-regulated genes involved in oxidative stress response, cell survival, and cardiac hypertrophy. At 1 month, the down-regulated genes included those involved in oxidative phosphorylation, mitochondrial dysfunction, nutrient metabolism, cardiac β-adrenergic signaling, action potential generation, and cell survival. We also found 96 overlapping DEGs at both ages involved in oxidative phosphorylation, mitochondrial function, and calcium signaling. Impaired oxidative phosphorylation was observed at early disease stage, even before the appearance of disease phenotypes, and worsened with disease progression, suggesting its importance in the pathogenesis and progression of LMNA cardiomyopathy. Reduction of oxidative stress might therefore prevent or delay the development from Lmna mutation to LMNA cardiomyopathy.

Highlights

  • Compared to microarrays, RNA-Sequencing technology produces discrete, digital sequencing read counts and can quantify expression across a larger dynamic range (>105 versus 103 for arrays) and detect a higher percentage of differentially expressed genes

  • While previous studies focused on specific pathways[8,10,11,12,13,14,15,16,18] in the pathogenesis of Lamin A/C (LMNA) cardiomyopathy, our study aimed to provide a systematic overview of the signaling pathways and pathophysiological changes that might synergistically contribute to the development of Lmna−/− induced LMNA cardiomyopathy

  • Unlike the former study, which showed a significant decrease in mouse weight in 2-week-old Lmna−/− mice[15], we did not identify a significant difference in growth between wild type (WT) and Lmna−/− mice at 1 week and 2 weeks of age (Fig. 1a)

Read more

Summary

Introduction

RNA-Sequencing technology produces discrete, digital sequencing read counts and can quantify expression across a larger dynamic range (>105 versus 103 for arrays) and detect a higher percentage of differentially expressed genes. While previous studies focused on specific pathways[8,10,11,12,13,14,15,16,18] in the pathogenesis of LMNA cardiomyopathy (caused by specific Lmna mutations or knockout), our study aimed to provide a systematic overview of the signaling pathways and pathophysiological changes that might synergistically contribute to the development of Lmna−/− induced LMNA cardiomyopathy. Our study is the first to identify the importance of impaired oxidative phosphorylation in the pathogenesis and progression of LMNA cardiomyopathy, suggesting the possibility that a reduction in oxidative stress might prevent or delay the development of LMNA cardiomyopathy in the presence of a Lmna gene mutation

Methods
Results
Conclusion
Full Text
Published version (Free)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call